Cargando…
Protease‐activated receptor‐mediated platelet aggregation in acute coronary syndrome patients on potent P2Y(12) inhibitors
BACKGROUND: Despite the increasing use of potent P2Y(12) inhibitors, further atherothrombotic events still impair the prognosis of many acute coronary syndrome (ACS) patients. This may in part be attributable to intact platelet aggregation via the human thrombin receptors protease‐activated receptor...
Autores principales: | Wadowski, Patricia P., Pultar, Joseph, Weikert, Constantin, Eichelberger, Beate, Panzer, Benjamin, Huber, Kurt, Lang, Irene M., Koppensteiner, Renate, Panzer, Simon, Gremmel, Thomas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6611376/ https://www.ncbi.nlm.nih.gov/pubmed/31294325 http://dx.doi.org/10.1002/rth2.12213 |
Ejemplares similares
-
Comparison of Light Transmission Aggregometry With Impedance Aggregometry in Patients on Potent P2Y12 Inhibitors
por: Wadowski, Patricia P., et al.
Publicado: (2020) -
Ticagrelor Inhibits Toll-Like and Protease-Activated Receptor Mediated Platelet Activation in Acute Coronary Syndromes
por: Wadowski, Patricia P., et al.
Publicado: (2020) -
Protease‐activated receptor‐mediated platelet aggregation in patients with type 2 diabetes on potent P2Y
(12) inhibitors
por: Panzer, Benjamin, et al.
Publicado: (2022) -
Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers in Acute Coronary Syndrome: Implications for Platelet Reactivity?
por: Tscharre, Maximilian, et al.
Publicado: (2020) -
Disaggregation Following Agonist-Induced Platelet Activation in Patients on Dual Antiplatelet Therapy
por: Wadowski, Patricia P., et al.
Publicado: (2017)